Results 1 to 10 of about 69,216 (297)

Alzheimer’s Disease–Thrombosis Comorbidity: A Growing Body of Evidence from Patients and Animal Models

open access: yesCells
Background/Objectives: A growing body of evidence is amassing in the literature suggesting a correlation between Alzheimer’s disease (AD) and thrombotic vascular complications, which led to the suggestive hypothesis that thrombosis may contribute to AD ...
Joanna Koch-Paszkowski   +2 more
doaj   +1 more source

Measuring multimorbidity in hospitalised patients using linked hospital episode data: comparison of two measures

open access: yesInternational Journal of Population Data Science, 2019
Introduction Multimorbidity is a complex and growing health challenge. There is no accepted “gold standard” multimorbidity measure for hospital resource planning, and few studies have compared measures in hospitalised patients.
Lynn Robertson   +4 more
doaj   +1 more source

Effect of multimorbidity on hypertension management

open access: yesScientific Reports, 2023
Multimorbidity, the coexistence of multiple health conditions, is associated with functional decline, disability, and mortality. We aimed to investigate the effects of multimorbidity on hypertension treatment and control rates by analyzing data from the ...
Eunjeong Ji   +4 more
doaj   +1 more source

Combined Use of Gefitinib and Bevacizumab in Advanced Non-Small-Cell Lung Cancer with EGFR G719S/S768I Mutations and Acquired C797S Without T790M After Osimertinib: A Case Report and Literature Review

open access: yesCurrent Oncology
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are effective in non-small-cell lung cancer (NSCLC) with sensitizing mutations.
Wenting Lu   +7 more
doaj   +1 more source

The association between multiple long‐term conditions and dementia: A UK cohort study

open access: yesAlzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
INTRODUCTION Studies examining the risk of dementia in people with multimorbidity are commonly conducted in research cohorts or outside the UK. Multimorbidity has historically been associated with aging, but recent research suggests that more than half ...
Hilary Shepherd   +5 more
doaj   +1 more source

Association between multimorbidity patterns and disability among older people covered by long-term care insurance in Shanghai, China

open access: yesBMC Public Health, 2021
Background Functional disability and multimorbidity are common among older people. However, little is known about the relationship between functional disability and different multimorbidity combinations.
Zijing Wang   +9 more
doaj   +1 more source

Social determinants of multimorbidity and multiple functional limitations among the ageing population of England, 2002–2015

open access: yesSSM: Population Health, 2019
This study explores longitudinal relationships between material, psycho-social and behavioural social determinants of health and multimorbidity of people aged 50 years or older in England.
Leo Singer   +4 more
doaj   +1 more source

Multi-omics analyses reveal biological and clinical insights in recurrent stage I non-small cell lung cancer

open access: yesNature Communications
Post-operative recurrence rates of stage I non-small cell lung cancer (NSCLC) range from 20% to 40%. Nonetheless, the molecular mechanisms underlying recurrence hitherto remain largely elusive.
Chengdi Wang   +11 more
doaj   +1 more source

Prevalence and patterns of chronic non-communicable disease multimorbidity in an Indonesian adult population

open access: yesPublic Health of Indonesia
Background: Chronic non-communicable diseases (NCDs) are a global health challenge, with increasing prevalence of multimorbidity. Objective: This study was to examine the prevalence of chronic NCDs and their multimorbidity patterns in the Indonesian ...
Hoirun Nisa   +4 more
doaj   +1 more source

Efficacy and safety of neoadjuvant targeted therapy in non-small cell lung cancer: a systematic review and meta-analysis

open access: yesSystematic Reviews
Introduction Epidermal growth factor receptor (EGFR) mutations are major oncogenic drivers in non-small cell lung cancer (NSCLC), occurring in 30–50% of Asian patients. Neoadjuvant EGFR-tyrosine kinase inhibitors (EGFR-TKIs) may improve surgical outcomes
Honglin Li   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy